1 |
Statistical optimization of culture medium to produce recombinant viral protein by Escherichia coli host for diagnostic kit to detect human immunodeficiency virus (HIV) infection Sekar A, Shin Y, Jeong H, Kim K Biochemical and Biophysical Research Communications, 504(4), 666, 2018 |
2 |
Phages and HIV-1: From Display to Interplay Delhalle S, Schmit JC, Chevigne A International Journal of Molecular Sciences, 13(4), 4727, 2012 |
3 |
Role for the disulfide-bonded region of human immunodeficiency virus type 1 gp41 in receptor-triggered activation of membrane fusion function Bellamy-McIntyre AK, Bar S, Ludlow L, Drummer HE, Poumbourios P Biochemical and Biophysical Research Communications, 394(4), 904, 2010 |
4 |
A recombinant mimetics of the HIV-1 gp41 prehairpin fusion intermediate fused with human IgG Fc fragment elicits neutralizing antibody response in the vaccinated mice Qi Z, Pan CE, Lu H, Shui YA, Li L, Li XJ, Xu XQ, Liu SW, Jiang SB Biochemical and Biophysical Research Communications, 398(3), 506, 2010 |
5 |
Interfacial properties and structure stability of the gp41 tryptophan-rich peptide from HIV-1 Matar G, Nasir MN, Besson F Journal of Colloid and Interface Science, 352(2), 520, 2010 |
6 |
Novel anti-HIV peptides containing multiple copies of artificially designed heptad repeat motifs Shi WG, Qi Z, Pan CG, Xue N, Debnath AK, Qie JK, Jiang SB, Liu KL Biochemical and Biophysical Research Communications, 374(4), 767, 2008 |
7 |
Deletion of fusion peptide or destabilization of fusion core of HIV gp41 enhances antigenicity and immunogenicity of 4E10 epitope Li J, Chen X, Jiang SB, Chen YH Biochemical and Biophysical Research Communications, 376(1), 60, 2008 |
8 |
The application of perfluorooctanoate to investigate trimerization of the human immunodeficiency virus-1 gp41 ectodomain by electrophoresis Lin CH, Chang CC, Cheng SF, Chang DK Electrophoresis, 29(15), 3175, 2008 |
9 |
HIV-1 gp41 ectodomain enhances Cryptococcus neoformans binding to HBMEC Jong AY, Wu CH, Jiang SB, Feng L, Chen HM, Huang SH Biochemical and Biophysical Research Communications, 356(4), 899, 2007 |
10 |
Rational design of highly potent HIV-1 fusion inhibitory proteins: Implication for developing antiviral therapeutics Ni L, Gao GF, Tien P Biochemical and Biophysical Research Communications, 332(3), 831, 2005 |